Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis

References

• Velázquez FR, Matson DO, Guerrero ML, Shults J, Calva JJ, Morrow AL, Glass RI, Pickering LK, Ruiz-Palacios GM. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis 2000; 182:1602 - 9; http://dx.doi.org/10.1086/317619; PMID: 11069230
   PubMed Web of Science ®Google Scholar
• Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K, Urasawa S, Nakao T. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986; 2:417 - 21; http://dx.doi.org/10.1016/S0140-6736(86)92133-1; PMID: 2874413
   PubMed Web of Science ®Google Scholar
• Hjelt K, Grauballe PC, Paerregaard A, Nielsen OH, Krasilnikoff PA. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J Med Virol 1987; 21:39 - 47; http://dx.doi.org/10.1002/jmv.1890210106; PMID: 3025356
   PubMed Web of Science ®Google Scholar
• Matson DO. Protective immunity against group A rotavirus infection and illness in infants. Arch Virol Suppl 1996; 12:129 - 39; PMID: 9015110
   PubMedGoogle Scholar
• O’Ryan ML, Matson DO, Estes MK, Pickering LK. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis 1994; 169:504 - 11; http://dx.doi.org/10.1093/infdis/169.3.504; PMID: 8158022
   PubMed Web of Science ®Google Scholar
• Wood D, WHO Informal Consultative Group. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005. Vaccine 2005; 23:5478 - 87; http://dx.doi.org/10.1016/j.vaccine.2005.07.035; PMID: 16129525
   PubMed Web of Science ®Google Scholar
• Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DW, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011; 365:337 - 46; http://dx.doi.org/10.1056/NEJMoa1006261; PMID: 21793745
   PubMed Web of Science ®Google Scholar
• Angel J, Franco MA, Greenberg HB. Rotavirus immune responses and correlates of protection. Curr Opin Virol 2012; 2:419 - 25; http://dx.doi.org/10.1016/j.coviro.2012.05.003; PMID: 22677178
   PubMed Web of Science ®Google Scholar
• Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002; 34:1351 - 61; http://dx.doi.org/10.1086/340103; PMID: 11981731
   PubMed Web of Science ®Google Scholar
• Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis 2013; 208:284 - 94; http://dx.doi.org/10.1093/infdis/jit166; PMID: 23596320
   PubMed Web of Science ®Google Scholar
• Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24:2718 - 31; http://dx.doi.org/10.1016/j.vaccine.2005.12.048; PMID: 16446014
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al, Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11 - 22; http://dx.doi.org/10.1056/NEJMoa052434; PMID: 16394298
   PubMed Web of Science ®Google Scholar
• Araujo EC, Clemens SA, Oliveira CS, Justino MC, Rubio P, Gabbay YB, da Silva VB, Mascarenhas JD, Noronha VL, Clemens R, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) 2007; 83:217 - 24; http://dx.doi.org/10.2223/JPED.1600; PMID: 17380232
   PubMed Web of Science ®Google Scholar
• Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8:431 - 40; http://dx.doi.org/10.1002/sim.4780080407; PMID: 2727467
   PubMed Web of Science ®Google Scholar
• De Vos B, Han HH, Bouckenooghe A, Debrus S, Gillard P, Ward R, Cheuvart B. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009; 28:261 - 6; http://dx.doi.org/10.1097/INF.0b013e3181907177; PMID: 19289978
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001; 20:63 - 75; http://dx.doi.org/10.1097/00006454-200101000-00013; PMID: 11176570
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289 - 98; http://dx.doi.org/10.1056/NEJMoa0904797; PMID: 20107214
   PubMed Web of Science ®Google Scholar
• Zeng SQ, Halkosalo A, Salminen M, Szakal ED, Karvonen A, Vesikari T. Norovirus gastroenteritis in young children receiving human rotavirus vaccine. Scand J Infect Dis 2010; 42:540 - 4; http://dx.doi.org/10.3109/00365541003652556; PMID: 20524782
   PubMed Web of Science ®Google Scholar
• Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 2006; 43:312 - 4; http://dx.doi.org/10.1086/505493; PMID: 16804845
   PubMed Web of Science ®Google Scholar
• Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, et al, Rota-024 Study Group. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J 2011; 30:e103 - 8; PMID: 21378594
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009; 27:5936 - 41; http://dx.doi.org/10.1016/j.vaccine.2009.07.098; PMID: 19679216
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Thollot F, Garcia-Corbeira P, Damaso S, Han HH, Bouckenooghe A. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2010; 28:5272 - 9; http://dx.doi.org/10.1016/j.vaccine.2010.05.057; PMID: 20538094
   PubMed Web of Science ®Google Scholar
• Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran PV, Han HH. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29:6335 - 41; http://dx.doi.org/10.1016/j.vaccine.2011.05.017; PMID: 21640780
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Puustinen L, Zeng SQ, Szakal ED, Delem A, De Vos B. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004; 23:937 - 43; http://dx.doi.org/10.1097/01.inf.0000141722.10130.50; PMID: 15602194
   PubMed Web of Science ®Google Scholar
• Salinas B, Pérez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzábal JP, Cervantes Y, Costa Clemens S, Damaso S, Hardt K, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005; 24:807 - 16; http://dx.doi.org/10.1097/01.inf.0000178294.13954.a1; PMID: 16148848
   PubMed Web of Science ®Google Scholar
• Phua KB, Emmanuel SC, Goh P, Quak SH, Lee BW, Han HH, Ward RL, Bernstein DI, De Vos B, Bock HL. A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore 2006; 35:38 - 44; PMID: 16470273
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757 - 63; http://dx.doi.org/10.1016/S0140-6736(07)61744-9; PMID: 18037080
   PubMed Web of Science ®Google Scholar
• Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259 - 67; http://dx.doi.org/10.3109/00365549009027046; PMID: 2371542
   PubMed Web of Science ®Google Scholar
• Gilchrist MJ, Bretl TS, Moultney K, Knowlton DR, Ward RL. Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay. Diagn Microbiol Infect Dis 1987; 8:221 - 8; http://dx.doi.org/10.1016/0732-8893(87)90053-8; PMID: 2835201
   PubMed Web of Science ®Google Scholar
• Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis 1986; 154:871 - 80; http://dx.doi.org/10.1093/infdis/154.5.871; PMID: 3021869
   PubMed Web of Science ®Google Scholar
• Ward RL, Bernstein DI, Shukla R, Young EC, Sherwood JR, McNeal MM, Walker MC, Schiff GM. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis 1989; 159:79 - 88; http://dx.doi.org/10.1093/infdis/159.1.79; PMID: 2535868
   PubMed Web of Science ®Google Scholar
• Lin DY, Fleming TR, De Gruttola V. Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 1997; 16:1515 - 27; http://dx.doi.org/10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.0.CO;2-1; PMID: 9249922
   PubMed Web of Science ®Google Scholar
• Tang ML, Ng HK. Comment on: confidence limits for the ratio of two rates based on likelihood scores: non-iterative method. Stat Med 2004; 23:685 - 90, author reply 891-2; http://dx.doi.org/10.1002/sim.1683; PMID: 14755397
   PubMed Web of Science ®Google Scholar
• Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41:55 - 68; http://dx.doi.org/10.2307/2530643; PMID: 4005387
   PubMed Web of Science ®Google Scholar